After our finding of the association of metformin treatment with the proportion of CD133+ CSCs in CRC of these patients, we further investigated the synergistic effect of metformin plus 5-FU treatment on the proportion of CD133+ cells and the expression of β-catenin protein in SW620 cells. Here, PROM1 is linked to colorectal carcinoma.